What Taurx Therapeutics Management say about themselves
“At TauRx, our mission is to make a positive difference to the lives of the individuals, carers and families affected by neurodegenerative diseases. Learn more about what we do today.”
Taurx Therapeutics Management Ltd.
- Incorporated
- 31 March 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Michael Thomas Dudley CooperJohn Storey
- Accounts type
- Full
- Region
- Scotland
- Address
- 395 King StreetAberdeenAB24 5RP
Website & contact details
- Website
Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 30 June 2025
- Conf. stmt due
- 13 April 2027
- Last conf. stmt
- 30 March 2026
Officers 4 active
Officer details are public data from the Companies House register.
Cooper, Michael Thomas Dudley, Dr
Director · Appointed 17 April 2025
British
Born June 1972 (54)
Director · Appointed 31 January 2022
Scottish
Born March 1970 (56)
Storey, John, Professor
Director · Appointed 31 January 2022
British
Born November 1965
British
Born June 1949 (77)
Officer history (1 former)
17 April 2025
Appointed Cooper, Michael Thomas Dudley, Dr as Director
31 January 2022
31 January 2022
Appointed Storey, John, Professor as Director
3 July 2020
31 March 2016
31 March 2016
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 7
Companies where Taurx Therapeutics Management Ltd. is registered as a person with significant control
Owns 25–50% of shares
Active
Owns 75–100% of shares
Dissolved
Owns 75–100% of shares
Active
Owns 75–100% of shares
Dissolved
Owns 75–100% of shares
Dissolved
Owns 75–100% of shares
Dissolved
Owns 75–100% of shares
Active
Former controllers (2)
17 May 2018
Ceased Taurx Therapeutics Limited — Owns 75–100% of shares
16 May 2018
Ceased Taurx Therapeutics Ltd. — Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 June 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£205,698)
- Debt Ratio
- 41157%
- Current Ratio
- 0.0x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £201 | £201 | £201 | £200 | £200 | |
| Current Assets | £300 | £300 | £300 | £300 | £300 | £500 |
| Creditors (< 1 year) | £206,199 | £10,018 | £5,021 | £189 | £189 | £176 |
| Net Current Assets | (£205,899) | (£9,718) | (£4,721) | £111 | £111 | £324 |
| Net Assets | (£205,698) | (£9,517) | (£4,520) | £311 | £311 | £324 |
| Shareholder Funds | (£205,698) | (£9,517) | (£4,520) | £311 | £311 | £324 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 7 July 2026 | Full accounts | 30 June 2025 | ||
| 13 April 2026 | Notification of a person with significant control statement | |||
| 13 April 2026 | Confirmation statement with updates | 30 March 2026 | ||
| 10 April 2026 | Withdrawal of a person with significant control statement | |||
| 30 July 2025 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
Edinburgh
Cambridge
Cambridge
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →